Bausch Health Companies Inc. (TSX:BHC)

Canada · Delayed Price · Currency is CAD

10.33

-0.47 (-4.35%)

At close: Jan 9, 2026

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Salix Revenue	2.52B	2.33B	Log In	Log In	Log In	Upgrade
International Rx Revenue	1.11B	1.11B	Log In	Log In	Log In	Upgrade
Solta Medical Revenue	519.00M	440.00M	Log In	Log In	Log In	Upgrade
Diversified Products Revenue	910.00M	950.00M	Log In	Log In	Log In	Upgrade
Bausch + Lomb Revenue	4.98B	4.79B	Log In	Log In	Log In	Upgrade
Ortho Dermatologies Revenue	-	-	Log In	Log In	Log In	Upgrade
Revenue (Other)	-755.58M	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	9.27B	9.63B	Log In	Log In	Log In	Upgrade

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Salix Segment Profit	1.86B	1.60B	Log In	Log In	Log In	Upgrade
International Rx Segment Profit	351.00M	376.00M	Log In	Log In	Log In	Upgrade
Solta Medical Segment Profit	250.00M	213.00M	Log In	Log In	Log In	Upgrade
Diversified Products Segment Profit	605.00M	626.00M	Log In	Log In	Log In	Upgrade
Bausch + Lomb Segment Profit	1.04B	1.11B	Log In	Log In	Log In	Upgrade
Ortho Dermatologies Segment Profit	-	-	Log In	Log In	Log In	Upgrade
Operating Income (Total)	1.72B	1.55B	Log In	Log In	Log In	Upgrade

Updated Sep 30, 2025. Data Source: Fiscal.ai.